16:55 Mutational Profiling in Patients with MDS: Ready for every-day use in the clinic? HMP Education
23:17 Erythropoiesis Stimulating Agents and other Growth Factors in Low-risk MDS: An update HMP Education
13:24 Mutation-based Risk Stratification Approaches in Myelofibrosis: Any real clinical utility? HMP Education
25:15 How to Manage Side Effects of JAK Inhibitors for Mylofibrosis in the Clinical Practice HMP Education
22:27 Influence of Mutational Status on Timing, Outcome, and Post-transplant Management of Myelofibrosis HMP Education
